Angiotensin Receptor Blockers in Aortic Stenosis
Aortic Stenosis | Aortic Valve StenosisThis study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
20 and up
Critères de participation
Inclusion Criteria:
* Mild to moderate aortic stenosis (peak aortic jet velocity ≥2.5 and \<4m/s)
* Normal left ventricular ejection fraction (i.e. ≥50%)
* Systolic blood pressure \>110 mmHg
* Diastolic blood pressure \>70 mmHg
Exclusion Criteria:
* More than mild aortic or mitral regurgitation, or mitral stenosis
* Current use or documented indication for renin-angiotensin system medication or Aliskiren
* Known allergy or intolerance to angiotensin II receptor blockers (ARBs)
* Alzheimer, dementia or known non-compliant patient
* Renal dysfunction (glomerular filtration rate \<30ml/min/1.73m2)
* Chronic hyperkalemia
* Diagnosed hepatic failure, cirrhosis, hepatitis or history of hepatic impairment
* Newly diagnosed (\<2 months) or poorly controlled diabetes
* Pre-existing obstructive coronary artery disease with CCS III-IV angina or recent myocardial infarction (\<3 months)
* Pregnant or lactating women
* Patients unable to read, understand or sign research consent
Lieu de l'étude
CRIUCPQ
CRIUCPQQuébec, Quebec
Canada
Contactez l'équipe d'étude
Marie-Annick Clavel
- Étude parrainée par
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT04913870